Status:
COMPLETED
The Effects of Peanuts and Peanut Products on Glucose Control and Vascular Function
Lead Sponsor:
Penn State University
Collaborating Sponsors:
Peanut Institute
Conditions:
Cardiovascular Disease
Eligibility:
MALE
20-50 years
Phase:
PHASE1
Brief Summary
Pilot study data have demonstrated that peanuts ameliorate the postprandial glucose and insulin response when incorporated into an acute high fat/high glucose meal. However, it is unclear whether acut...
Eligibility Criteria
Inclusion
- 20-50 years of age
- LDL-C below 160 mg/dL
- Triglyceride below 350 mg/dL
- Blood pressure within normal ranges (below 140/90 mmHg)
- Not taking medication for elevated lipids, blood pressure or glucose
Exclusion
- Allergies to peanuts or dairy products
- Known intolerance for high fat meals
- History of cardiovascular disease (CVD), kidney disease, diabetes or inflammatory diseases such as GI disorders and arthritis
- Use of non-steroidal anti-inflammatories or immunosuppressants
- Conditions requiring the use of steroids
- Use of medication or supplements for elevated lipids, blood pressure or glucose
- Donation of blood or plasma during the study
- History of thyroid disease
- Women
- Lactose intolerance
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01405300
Start Date
August 1 2011
End Date
June 1 2014
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State University
University Park, Pennsylvania, United States, 16802